These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 26223134)

  • 21. Molecular-level insight into hot-melt loading and drug release from mesoporous silica carriers.
    Lizoňová D; Mužík J; Šoltys M; Beránek J; Kazarian SG; Štěpánek F
    Eur J Pharm Biopharm; 2018 Sep; 130():327-335. PubMed ID: 30012403
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and characterization of mesoporous silica and its application as drug delivery system for glimepiride.
    Muhana F; Al-Ani I; Al-Akayleh F; Marzouqa D; Khalili F; Al-Khatib H; Mutti H; Shalan N
    Pharmazie; 2021 Jul; 76(7):300-307. PubMed ID: 34256891
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Formulation and optimization of drug-loaded mesoporous silica nanoparticle-based tablets to improve the dissolution rate of the poorly water-soluble drug silymarin.
    Ibrahim AH; Smått JH; Govardhanam NP; Ibrahim HM; Ismael HR; Afouna MI; Samy AM; Rosenholm JM
    Eur J Pharm Sci; 2020 Jan; 142():105103. PubMed ID: 31648050
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of particle morphology, pore size and surface coating of mesoporous silica on Naproxen dissolution rate enhancement.
    Guo Z; Liu XM; Ma L; Li J; Zhang H; Gao YP; Yuan Y
    Colloids Surf B Biointerfaces; 2013 Jan; 101():228-35. PubMed ID: 23010024
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ordered nanoporous silica as carriers for improved delivery of water insoluble drugs: a comparative study between three dimensional and two dimensional macroporous silica.
    Wang Y; Zhao Q; Hu Y; Sun L; Bai L; Jiang T; Wang S
    Int J Nanomedicine; 2013; 8():4015-31. PubMed ID: 24174875
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modifying release of poorly soluble active pharmaceutical ingredients with the amine functionalized SBA-16 type mesoporous materials.
    Jadach B; Feliczak-Guzik A; Nowak I; Milanowski B; Piotrowska-Kempisty H; Murias M; Lulek J
    J Biomater Appl; 2019 Apr; 33(9):1214-1231. PubMed ID: 30791849
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nanoconfinement of a Pharmaceutical Cocrystal with Praziquantel in Mesoporous Silica: The Influence of the Solid Form on Dissolution Enhancement.
    Salas-Zúñiga R; Mondragón-Vásquez K; Alcalá-Alcalá S; Lima E; Höpfl H; Herrera-Ruiz D; Morales-Rojas H
    Mol Pharm; 2022 Feb; 19(2):414-431. PubMed ID: 34967632
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Improving the dissolution rate of poorly water-soluble resveratrol by the ordered mesoporous silica].
    Quan GL; Chen B; Wang ZH; Wu H; Huang XT; Wu LN; Wu CB
    Yao Xue Xue Bao; 2012 Feb; 47(2):239-43. PubMed ID: 22512038
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Magnetic Fe3O4@mesoporous silica composites for drug delivery and bioadsorption.
    Huang S; Li C; Cheng Z; Fan Y; Yang P; Zhang C; Yang K; Lin J
    J Colloid Interface Sci; 2012 Jun; 376(1):312-21. PubMed ID: 22444483
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis of novel core-shell structured dual-mesoporous silica nanospheres and their application for enhancing the dissolution rate of poorly water-soluble drugs.
    Wu C; Sun X; Zhao Z; Zhao Y; Hao Y; Liu Y; Gao Y
    Mater Sci Eng C Mater Biol Appl; 2014 Nov; 44():262-7. PubMed ID: 25280705
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhancing in vitro dissolution and in vivo bioavailability of fenofibrate by solid self-emulsifying matrix combined with SBA-15 mesoporous silica.
    Quan G; Wu Q; Zhang X; Zhan Z; Zhou C; Chen B; Zhang Z; Li G; Pan X; Wu C
    Colloids Surf B Biointerfaces; 2016 May; 141():476-482. PubMed ID: 26896653
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of a tin oxide carrier with mesoporous structure for improving the dissolution rate and oral relative bioavailability of fenofibrate.
    Bai A; Wu C; Liu X; Lv H; Xu X; Cao Y; Shang W; Hu L; Liu Y
    Drug Des Devel Ther; 2018; 12():2129-2138. PubMed ID: 30022811
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inclusion and release of fenbufen in mesoporous silica.
    Carriazo D; del Arco M; Fernández A; Martín C; Rives V
    J Pharm Sci; 2010 Aug; 99(8):3372-80. PubMed ID: 20232455
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A stand-alone mesoporous crystal structure model from in situ X-ray diffraction: nitrogen adsorption on 3D cagelike mesoporous silica SBA-16.
    Miyasaka K; Hano H; Kubota Y; Lin Y; Ryoo R; Takata M; Kitagawa S; Neimark AV; Terasaki O
    Chemistry; 2012 Aug; 18(33):10300-11. PubMed ID: 22829334
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of ordered mesoporous silica as a carrier for poorly soluble drugs: influence of pressure on the structure and drug release.
    Vialpando M; Aerts A; Persoons J; Martens J; Van Den Mooter G
    J Pharm Sci; 2011 Aug; 100(8):3411-3420. PubMed ID: 21387318
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Drug Release Model Constructed by Factorial Design to Investigate the Interaction Between Host Mesoporous Silica Carriers and Drug Molecules.
    Liu T; Wang K; Jiang M; Wan L
    AAPS PharmSciTech; 2019 Feb; 20(3):126. PubMed ID: 30809738
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Luminescence functionalization of SBA-15 by YVO4:Eu3+ as a novel drug delivery system.
    Yang P; Huang S; Kong D; Lin J; Fu H
    Inorg Chem; 2007 Apr; 46(8):3203-11. PubMed ID: 17371013
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interplay of Adsorption, Supersaturation and the Presence of an Absorptive Sink on Drug Release from Mesoporous Silica-Based Formulations.
    Hate SS; Reutzel-Edens SM; Taylor LS
    Pharm Res; 2020 Aug; 37(8):163. PubMed ID: 32754797
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biomimetic synthesized chiral mesoporous silica: Structures and controlled release functions as drug carrier.
    Li J; Xu L; Yang B; Bao Z; Pan W; Li S
    Mater Sci Eng C Mater Biol Appl; 2015 Oct; 55():367-72. PubMed ID: 26117767
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Study on formulation variables of methotrexate loaded mesoporous MCM-41 nanoparticles for dissolution enhancement.
    Vadia N; Rajput S
    Eur J Pharm Sci; 2012 Jan; 45(1-2):8-18. PubMed ID: 22067974
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.